Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | AMGN | CELG | GILD | BIIB |
| Company | Ligand Pharm | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 79.47 | 266.83 | 108.01 | 67.80 | 196.20 |
| High | 81.52 | 267.51 | 108.59 | 67.89 | 197.73 |
| Low | 79.06 | 263.81 | 107.27 | 67.18 | 194.94 |
| Last | 79.92 | 265.64 | 108.24 | 67.31 | 195.15 |
| Change | +0.15 | +0.13 | +0.11 | -0.44 | -1.65 |
| % Change | +0.19% | +0.05% | +0.10% | -0.65% | -0.84% |
| Volume | 158,400 | 2,017,500 | 191,230,496 | 4,974,900 | 871,900 |
| 20-Day Average Volume | 145,200 | 2,269,115 | 16,188,930 | 6,427,060 | 1,092,630 |
| Previous Close | 79.77 | 265.51 | 108.13 | 67.75 | 196.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 75.67 | 273.86 | 108.17 | 70.93 | 209.06 |
| 20-Day Raw Stochastic | 86.58% | 7.39% | 63.25% | 1.83% | 0.78% |
| 20-Day Relative Strength | 58.82% | 38.83% | 64.69% | 30.61% | 29.58% |
| Weighted Alpha | +14.22 | +5.85 | +46.30 | -23.45 | -36.64 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Last Month's Opinion | 64% Buy | 8% Sell | 100% Buy | 72% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.94% since 04/09/24 | -1.75% since 04/09/24 | -1.97% since 11/13/19 | -3.76% since 04/09/24 | -5.51% since 04/09/24 |
| Low | 78.88 on 04/10/24 | 263.81 on 04/16/24 | 107.27 on 11/20/19 | 67.18 on 04/16/24 | 194.94 on 04/16/24 |
| High | 81.73 on 04/12/24 | 273.00 on 04/11/24 | 110.53 on 11/14/19 | 69.76 on 04/10/24 | 205.24 on 04/12/24 |
| 1-Month | |||||
| %Chg | +12.42% since 03/15/24 | -1.20% since 03/15/24 | +5.14% since 10/18/19 | -8.66% since 03/15/24 | -11.02% since 03/15/24 |
| Low | 68.25 on 03/26/24 | 263.81 on 04/16/24 | 102.40 on 10/21/19 | 67.18 on 04/16/24 | 194.94 on 04/16/24 |
| High | 81.73 on 04/12/24 | 288.57 on 03/28/24 | 110.70 on 11/13/19 | 74.28 on 03/21/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +12.45% since 01/16/24 | -12.47% since 01/16/24 | +13.63% since 08/20/19 | -21.72% since 01/16/24 | -20.73% since 01/16/24 |
| Low | 67.53 on 01/17/24 | 263.81 on 04/16/24 | 93.41 on 08/23/19 | 67.18 on 04/16/24 | 194.94 on 04/16/24 |
| High | 94.57 on 02/27/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | +41.65% since 10/16/23 | -7.40% since 10/16/23 | +14.14% since 05/20/19 | -15.01% since 10/16/23 | -27.17% since 10/16/23 |
| Low | 49.24 on 10/27/23 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 67.18 on 04/16/24 | 194.94 on 04/16/24 |
| High | 94.57 on 02/27/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 269.43 on 10/17/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,412,327 | 142,291,856 | 77,035,920 | 84,353,968 | 28,607,044 |
| Shares Outstanding, K | 17,705 | 535,919 | 711,714 | 1,245,077 | 145,361 |
| Annual Sales | 131,310,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | 52,150,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 28,100,000 | 8,196,000,000 | 4,520,000,000 | 7,114,000,000 | 2,386,300,000 |
| Last Quarter Net Income | 18,190,000 | 767,000,000 | 1,691,000,000 | 1,429,000,000 | 249,700,000 |
| 60-Month Beta | 1.01 | 0.58 | 1.41 | 0.19 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.05 on 02/27/24 | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 1.72 on 02/06/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | 2.500 on 04/03/07 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 17.84 | 14.33 | 10.99 | 10.13 | 13.45 |